This simulator was made to show people how glaucoma can change vision over time.
To begin, click on the button and drag it to the right, or just click different points on the white line. You will see a simulation of how glaucoma can progress if left untreated.
This video requires a Flash player and JavaScript. If you don't have the latest version, you can download the player free of charge.
Fortunately, high eye pressure, which can lead to glaucoma, can be treated. XALATAN is your partner in the fight against glaucoma. Take control of your eye health and talk to your doctor.
Next: Video Library
XALATAN is for the treatment of high eye pressure/intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension.
Like all medicines, XALATAN can have side effects. These side effects are usually mild and tolerable and may include blurred vision, burning and stinging, eye redness, the feeling of something in the eye, eye itching, increased pigmentation (darkening) of eye color, or irritation of the clear front surface of the eye.
XALATAN may slowly cause darkening of the eye color due to increased brown color, darkening of the eyelid and eyelashes, and increased growth and thickness of eyelashes. Color changes can increase as long as XALATAN is administered and eye color changes are likely to be permanent.
The recommended dosage is one drop (1.5 µg) in the affected eye(s) once daily in the evening. If one dose is missed, treatment should continue with the next dose as normal.
There have been reports of bacterial keratitis associated with the use of multiple-dose containers of topical ophthalmic products.
This Web site is intended for residents of the United States only. The products discussed herein may have different product labeling in different countries.
The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a health care provider. All decisions regarding patient care must be made with a health care provider, considering the unique characteristics of the patient.
Pfizer is a licensee of the TRUSTe Privacy Program© 2008 Pfizer Inc. All rights reserved.
XLU00206B